Nimotuzumab with intensity-modulated radiation therapy in unresectable and platinum-ineligible locally advanced head-and-neck cancer

BACKGROUND: Outcomes with conventional treatment are poor in patients with squamous cell carcinoma of head and neck (SCCHN). Treatment options are further limited for patients ineligible to receive platinum-based chemotherapy due to various factors such as geriatric age, comorbidity, and organ dysfu...

Descripción completa

Detalles Bibliográficos
Autores principales: Srinivas, K. Satish, Sundaram, Raja, Divyambika, C. V., Chaudhari, Sameer
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2020
Materias:
ORIGINAL ARTICLE: Head and Neck Cancers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6956585/
https://www.ncbi.nlm.nih.gov/pubmed/31956621
http://dx.doi.org/10.4103/sajc.sajc_29_19

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6956585/
https://www.ncbi.nlm.nih.gov/pubmed/31956621
http://dx.doi.org/10.4103/sajc.sajc_29_19

Ejemplares similares